Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals Inc
WKN: A2AFXS / Symbol: CRVS / Name: Corvus / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
1,84 €
17,80 %
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $4.00 price target on the stock.
Ratings data for CRVS provided by MarketBeat
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $8.00 to $7.00. They now have an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target raised by analysts at Oppenheimer Holdings Inc. from $7.00 to $8.00. They now have an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Neueste Beiträge
Wedbush in Scholar Rock Holding diskutieren